Cronos Group, Inc. (CRON)
3.38
-0.01
(-0.30%)
USD |
NASDAQ |
Aug 28, 16:00
3.375
0.00 (0.00%)
After-Hours: 20:00
Cronos Group Enterprise Value : 506.10M for Aug. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 506.10M |
| August 27, 2026 | 509.81M |
| August 26, 2026 | 569.13M |
| August 25, 2026 | 554.30M |
| August 24, 2026 | 517.22M |
| August 21, 2026 | 480.15M |
| August 20, 2026 | 446.79M |
| August 19, 2026 | 472.74M |
| August 18, 2026 | 443.08M |
| August 17, 2026 | 420.84M |
| August 14, 2026 | 417.13M |
| August 13, 2026 | 424.54M |
| August 12, 2026 | 428.25M |
| August 11, 2026 | 394.89M |
| August 10, 2026 | 365.23M |
| August 07, 2026 | 402.30M |
| August 06, 2026 | 391.18M |
| August 05, 2026 | 261.42M |
| August 04, 2026 | 294.79M |
| August 03, 2026 | 302.20M |
| July 31, 2026 | 302.20M |
| July 30, 2026 | 324.45M |
| July 29, 2026 | 313.33M |
| July 28, 2026 | 309.62M |
| July 27, 2026 | 313.33M |
| Date | Value |
|---|---|
| July 24, 2026 | 294.79M |
| July 23, 2026 | 268.84M |
| July 22, 2026 | 283.67M |
| July 21, 2026 | 291.08M |
| July 20, 2026 | 291.08M |
| July 17, 2026 | 287.37M |
| July 16, 2026 | 272.55M |
| July 15, 2026 | 268.84M |
| July 14, 2026 | 272.55M |
| July 13, 2026 | 272.55M |
| July 10, 2026 | 272.55M |
| July 09, 2026 | 283.67M |
| July 08, 2026 | 272.55M |
| July 07, 2026 | 272.55M |
| July 06, 2026 | 276.25M |
| July 02, 2026 | 313.33M |
| July 01, 2026 | 313.33M |
| June 30, 2026 | 283.67M |
| June 29, 2026 | 301.94M |
| June 26, 2026 | 286.89M |
| June 25, 2026 | 256.79M |
| June 24, 2026 | 249.27M |
| June 23, 2026 | 241.74M |
| June 22, 2026 | 226.69M |
| June 18, 2026 | 249.27M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Lexaria Bioscience Corp. | 13.18M |
| Target Group, Inc. (Canada) | 11.90M |
| Tilray Brands, Inc. | 746.03M |
| InMed Pharmaceuticals, Inc. | -0.207M |
| NervGen Pharma Corp. | 181.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 35.66M |
| Revenue (Quarterly) | 53.01M |
| Total Expenses (Quarterly) | 20.92M |
| EPS Diluted (Quarterly) | 0.0855 |
| Gross Profit Margin (Quarterly) | 52.96% |
| Profit Margin (Quarterly) | 67.28% |
| Earnings Yield | 5.45% |
| Normalized Earnings Yield | 5.858 |